Feb. 23, 2024
by Andrii Buvailo, PhD
Interview
In a recent interview with Laurence Barker, a partner at SV Health Investors and a key figure in the Dementia …
Feb. 22, 2024
by Andrii Buvailo, PhD
News
In a collaborative effort, Zapata Computing (Zapata AI), together with Insilico Medicine, the University of Toronto, and St. Jude Children's …
Feb. 21, 2024
by BiopharmaTrend
News
Insilico Medicine, a leader in AI-driven drug discovery, has developed a new preclinical candidate, ISM9682, aimed at treating advanced solid …
Feb. 21, 2024
by BiopharmaTrend
News
Absci has embarked on IND-enabling studies for ABS-101, an anti-TL1A antibody, leveraging its generative AI technology to streamline the development …
Feb. 19, 2024
by Andrii Buvailo, PhD
Biopharma insight
Sponsored by RECEPTOR.AI
Receptor.AI, a London-based drug discovery company and NVIDIA Inception member, has successfully integrated NVIDIA BioNeMo cloud APIs with their end-to-end …
Feb. 13, 2024
by Dana Sokolova
Biopharma insight
The biotech and pharmaceutical industries are entering 2024 amid a wave of innovation and technological advancement. The biopharma field is …
Feb. 7, 2024
by Roman Kasianov
News
Ultima Genomics, Inc., a pioneer in genomic sequencing technology, has introduced the UG 100™, a groundbreaking sequencer designed to significantly …
Feb. 7, 2024
by Roman Kasianov
News
Exscientia plc, a UK-based AI-driven precision medicine company, has initiated a clinical study, EXCYTE-2, focusing on acute myeloid leukaemia (AML) patients. …
Feb. 6, 2024
by Andrii Buvailo, PhD
Interview
As we stand at the crossroads of artificial intelligence (AI) and biotech, what future awaits protein design, and how are …
Feb. 6, 2024
by Andrii Buvailo, PhD
Interview
In this episode, I dive deep into the burgeoning digital health landscape of the United Arab Emirates, a region rapidly …
Feb. 5, 2024
by Marco Schmidt
Biopharma insight
The term "Innovator's Dilemma" was coined by Clayton Christensen in 1997. The Innovator's Dilemma refers to a situation where successful, …
Feb. 2, 2024
by News Team
News
Aqemia, a Paris-based biotech startup, raised an additional €30 million in a Series A funding extension, totaling €60 million in …